Michael Castagna Podcast Cover Art

Michael Castagna, CEO, MannKind Corporation
ROI Podcast Episode 124

In CEO Podcast Series by Brandt A. Handley

Michael Castagna is our Chief Executive Officer and serves on the Board of Directors for MannKind Corporation. Dr. Castagna has over 20 years of experience in healthcare, pharmaceutical, biotech, and specialty pharmacy industries. He joins MannKind from Amgen, Inc., where he spent over three years as Vice President, Global Commercial Lead for a portfolio of nine biosimilar drugs, and Vice President, Global Lifecycle Management. Prior to Amgen, Dr. Castagna was Executive Director of Bristol-Myers Squibb’s Immunology franchise, where he served as co-lead to relaunch Orencia IV and launch Orencia SC, both rheumatoid arthritis drugs. Before BMS, Dr. Castagna was with Sandoz (Novartis) as Vice President and Division Head for Biopharmaceuticals, North America, where he established the US Biologics Business Unit and relaunched its lead product, Omnitrope, a human growth hormone. Prior to Sandoz, Michael held a variety of positions with EMD (Merck), Serono, Pharmasset, and DuPont Pharmaceuticals. Michael Castagna received his Bachelors of Science – Pharmacy degree from Philadelphia College of Pharmacy, his Doctor of Pharmacy from Massachusetts College of Pharmacy, and his MBA from the Wharton School of Business at the University of Pennsylvania.

How MannKind is changing lives for the better:

Drawing on the legacy of innovator and humanitarian Alfred E. Mann, we aim to develop therapeutic products and technologies that can help people manage serious medical conditions so that they can experience the very best that life has to offer.

With our ultra rapid-acting inhaled insulin, Afrezza®, we are changing the way diabetes is treated and, with our innovative Technosphere® technology, we are developing new ways for people with endocrine and orphan lung diseases to truly thrive.

We are driven to find new ways to change lives for the better. To keep working toward a world without limit for all.

To help more people live life more humann.SM